This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Amanda Haas
Business Development Manager, Gene Editing Therapeutics at Agilent Technologies
Speaker

Profile

Amanda Haas is a Business Development Manager at Agilent Technologies with over 19 years of experience in life sciences and biotechnology. She has been with Agilent for 3 years, growing gene editing therapeutic services, using market research, voice of the customer and collaborating with the development team. Amanda holds a B.S. degree in Chemistry from the University of Miamy. She previously worked at Horizon Discovery, Dharmacon, and Thermo Fisher Scientific.


Agenda Sessions

  • Streamline Your Nucleic Acid Therapeutics Development and Manufacturing

    11:50